ArticleStatistics in biopharmaceutical research2025

Joint TITE-CRM: A Design for Dose Finding Studies for Therapies with Late-Onset Safety and Activity Outcomes.

Helen Barnett et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.